Flynn Pharma

4 articles about Flynn Pharma

• 

  Pfizer and Flynn Under Fire Again for Alleged Overpricing of Anti-Epilepsy Drug

  7/22/2022

  Pfizer and Flynn Pharma are under the scrutiny of British watchdogs once again, after officials said the companies have been overcharging for an anti-epilepsy medication in the U.K. for over four years.
• 

  UK Watchdog Group Accuses Pfizer, Flynn Pharma of Price Gouging on Epilepsy Drug

  8/5/2021

  A United Kingdom watchdog organization has accused Pfizer and Flynn Pharma of violating antitrust rules and overcharging that country’s National Health Services for anti-epilepsy treatments.

• Neurim Pharmaceuticals' New Paediatric Prolonged-Release Melatonin ('Pedprm') To Be Marketed By Flynn Pharma In UK And Ireland

  9/25/2017

• Flynn Pharma Acquires Rights From Pacira Pharmaceuticals, Inc. to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe

  9/27/2007